ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 23 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $956,000 | -40.7% | 248,992 | -38.8% | 0.03% | -53.0% |
Q3 2019 | $1,611,000 | -8.0% | 406,926 | -2.2% | 0.07% | +4.8% |
Q2 2019 | $1,751,000 | -46.3% | 415,908 | -12.5% | 0.06% | -49.6% |
Q1 2019 | $3,262,000 | +86.4% | 475,450 | 0.0% | 0.12% | +78.6% |
Q4 2018 | $1,750,000 | -54.9% | 475,450 | -22.4% | 0.07% | -49.6% |
Q3 2018 | $3,879,000 | -43.9% | 612,867 | -32.9% | 0.14% | -42.8% |
Q2 2018 | $6,912,000 | -5.4% | 913,100 | 0.0% | 0.24% | -4.0% |
Q1 2018 | $7,305,000 | -28.6% | 913,100 | 0.0% | 0.25% | -37.1% |
Q4 2017 | $10,227,000 | -5.5% | 913,100 | -2.1% | 0.40% | -17.6% |
Q3 2017 | $10,824,000 | – | 933,100 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,571,450 | $27,257,000 | 2.19% |
Omega Fund Management, LLC | 1,284,900 | $13,620,000 | 1.29% |
Samsara BioCapital, LLC | 399,190 | $4,231,000 | 0.78% |
Soleus Capital Management, L.P. | 313,064 | $3,318,000 | 0.60% |
Avidity Partners Management LP | 1,511,000 | $16,017,000 | 0.44% |
Dorsey Wright & Associates | 3,380 | $35,828,000 | 0.42% |
EcoR1 Capital, LLC | 741,290 | $7,858,000 | 0.35% |
Orbimed Advisors | 3,070,955 | $32,552,000 | 0.30% |
TIGER MANAGEMENT L.L.C. | 137,728 | $1,460,000 | 0.29% |
DAFNA Capital Management LLC | 113,302 | $1,201,000 | 0.28% |